Posted on Leave a comment

Aplastic Anemia Market to witness growth by 2034, estimates DelveInsight | Pfizer, BioLineRx, Ltd., Regeneron Pharmaceuticals, Gamida Cell, Elixirgen, Hangzhou Zede Pharmaceutical Technology

Aplastic Anemia Market (Albany, USA) DelveInsight’s “Aplastic Anemia Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of Aplastic Anemia, historical and forecasted epidemiology as well as the Aplastic Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Aplastic Anemia market report provides current […]

Posted on Leave a comment

Community-Acquired Bacterial Pneumonia Market to Witness Growth by 2032, Estimates DelveInsight | Johnson & Johnson, Pfizer Inc., Dainippon Sumitomo Pharma, Takeda Pharma

“Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the 7MM. “Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical […]

Posted on Leave a comment

CAR-T Cell Therapy Competitive Landscape 2023 (Updated)

DelveInsight’s, “CAR T Cell Therapy Competitive Landscape 2023” report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T – Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.   […]

Posted on Leave a comment

Presbyopia Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Santen Pharma, Glaukos Corporation, Ocuphire

(Las Vegas, Nevada, United States)  As per DelveInsight’s assessment, globally, Presbyopia pipeline constitutes 12+ key companies continuously working towards developing 12+ Presbyopia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.  The Presbyopia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]

Posted on Leave a comment

Advanced Endometrial Cancer Pipeline Outlook Report 2024

DelveInsight’s, “Advanced Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 25+ Advanced Endometrial Cancer companies and 25+ pipeline drugs in the Advanced Endometrial Cancer pipeline landscape. It covers the Advanced Endometrial Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Advanced Endometrial Cancer pipeline therapeutics assessment by product […]

Posted on Leave a comment

Non Muscle Invasive Bladder Cancer Pipeline Outlook Report 2024

DelveInsight’s, “Non-Muscle Invasive Bladder Cancer Pipeline Insight 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Non-Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non-Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non-Muscle Invasive Bladder Cancer pipeline therapeutics assessment by […]

Posted on Leave a comment

Pompe Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | M6P Therapeutics, Entrada Therapeutics, Maze Therapeutics, Astellas

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Pompe Disease pipeline constitutes 15+ key companies continuously working towards developing 20+ Pompe Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Pompe Disease Pipeline report embraces in-depth commercial and clinical assessment of the […]

Posted on Leave a comment

Osteogenesis Imperfecta Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Mereo BioPharma, Amgen Pharmaceuticals

“Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the 7MM. The Osteogenesis Imperfecta market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various […]

Posted on Leave a comment

Post-Traumatic Stress Disorder Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Merck KGaA, Pfizer Inc.

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Post-Traumatic Stress Disorder pipeline constitutes 20+ key companies continuously working towards developing 22+ PTSD treatment therapies, analysis of Clinical Trials, Therapies, MOA, ROA, and Developments analyzes DelveInsight. The Post-Traumatic Stress Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]

Posted on Leave a comment

$118.9 Billion Medical Device Contract Manufacturing Market Insights by MarketsandMarkets™”

Browse 317 market data Tables and 62 Figures spread through 413 Pages and in-depth TOC on “Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Pumps), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgery) Class of Device (I, II, III) Services – Global Forecast to 2027 Key players in the medical device […]